Betamethasone valerate emulsion hydrophilic 0,025/0,05 or 0,1 % (nrf 11.47.)

Formulation

This section has been translated automatically.

Hydrophilic, non-ionic betamethasone valerate lotio of type O/W (containing cortisone) for external use. Apply a thin layer initially 2 times/day, then 1 time / day to the diseased skin areas.

Period of use: 6 months

Remark: Betamethasone valerate tends to isomerize in strongly acidic and alkaline environments (Wolf G 2014). The molecule loses about 85% of its effect. Therefore, NRF 11.47. as well as the hydrophilic cream of betamethasone valerate (NRF 11.37.) provides for the addition of a citrate buffer (pH 4.2).

Lit.: Wolf G (2014) Complex interactions between active substance and base. Dermatologist 65: 486-487

Entries in which this recipe is mentioned:

• Bacteride Andrews, pustular
• Betamethasone valerate
• Culicosis
• Dermatitis, Berloque dermatitis
• dermatitis bullosa pratensis
• Dermatitis, exudative discoid lichenoid
• dermatitis herpetiformis
• papulosa juvenilis dermatitis
• Dermatitis, phototoxic
• solar dermatitis
• Dermatosis, acute febrile neutrophilic
• Eczema, photoallergic
• Eczema, post-scabious
• Eczema, seborrhoic
• Embolia cutis medicamentosa
• Erythema exsudativum multiforme
• Erythema gyratum repens
• folliculitis decalvans
• Gamasidiosis
• Granuloma anulare disseminatum
• Granuloma fissuratum
• Hydrophilic betamethasone valerate emulsion 0,05 or 0,1 % (NRF 11.47.)
• Contact urticaria
• lichen sclerosus et atrophicus
• Light dermatosis, polymorphic
• lymphoma, cutaneous T-cell lymphoma, angioimmunoblastic
• melanodermia factitia
• follicular mucinosis
• Plant dermatitis
• prurigo simplex subacuta
• diabetic pruritus
• Pulicosis
• Pustulose, sterile eosinophils
• Pustulose, subcorneal
• pustulosis acuta generalisata
• acute radiodermatitis
• Stevens-Johnson syndrome
• Trombidiosis
• Urticaria pigmentosa bullosa
• Incineration
• Vulva atrophy, primary
• Cellulite, eosinophil